IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Disclosure Of Related Party Transactions
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions in the format specified under SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22nd November, 2021, for the half year ended on 30th September 2022. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Earnings Conference Call organized by the Company on 15th November 2022
Results Earnings Call for Q2FY23 of IOL Chemicals and Pharmaceuticals
Conference Call with IOL Chemicals and Pharmaceuticals Management and Analysts on Q2FY23 Performance and Outlook. Listen to the full earnings transcript. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Audio Recording Of Analysts/Investors Conference Call Pertaining To The Financial Results For Q2 & FY23
Audio Recording of Analysts/Investors Conference Call pertaining to the Financial Results for Q2 & FY23 IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of newspaper publication of Audited Financial Results for the quarter and half year ended 30th September 2022 IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation Q2FY23 Q2FY23 Quarterly Result Announced for IOL Chemicals and Pharmaceuticals Ltd.
IOL Chemicals and Pharmaceuticals announced Q2FY23 results: Total income stood at Rs 546 crore against Rs 570 crore QoQ and Rs 548 crore YoY EBITDA at Rs 37 crore as compared to Rs 61 crore QoQ and Rs 54 crore YoY Net profit of the Company at Rs 15.6 crore against Rs 34.9 crore QoQ and Rs 30.8 crore YoY Sanjay Chaturvedi, Executive Director & CEO, said, “The global economy is going through a roller-coaster ride as central banks battle inflation through rate hikes. Apart from inflation, global trade is also impacted by the uncertain business environment following Russia’s invasion of Ukraine and frequent lockdowns in China, thereby leading to supply chain disruptions. For the Indian API manufacturers and speciality chemicals players, the major challenge comes from volatile input costs with raw material and energy prices both impacting profitability. However, we expect the headwinds to subside going into the second half of this financial year and strongly believe that the worst is behind us in terms of challenges. IOL Chemicals has improved the operational efficiency over the last few quarters and we believe this would give us an edge in terms of expanding our margins next quarter onwards.” Result PDF IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Press Release
Press Release: IOL Chemicals and Pharmaceuticals Reports Q2 FY23 Results IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 14Th November 2022 And Submission Of Audited Financial Results For The Quarter And Half Year Ended 30Th September 2022
Pursuant to Regulations 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 14th November 2022 has inter alia considered and approved: 1. The Audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September 2022. Copy of the said Financial Results along with unmodified Auditors Report thereon is enclosed herewith as Annexure 1. 2. Conversion of Unit 9 as multiproduct facility to manufacture other pharma products. We hereby confirm and declare that Auditors Report issued by the Statutory Auditors on the financial results of the Company for the quarter and half year ended 30th September 2022 is an Unmodified Report. The meeting of Board of Directors commenced at 4:30 PM and concluded at 6:15 PM. The above Audited Financial Results are also available on the website of the Company i.e. www.iolcp.com.